Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 4 (5), 385-90

Update on Overactive Bladder: Pharmacologic Approaches on the Horizon

Affiliations
Review

Update on Overactive Bladder: Pharmacologic Approaches on the Horizon

Eric S Rovner et al. Curr Urol Rep.

Abstract

Limitations exist with regard to the array of available agents for the pharmacologic therapy of overactive bladder, including issues of efficacy and tolerability. It is clear that the ideal agent for this condition has not been identified. However, several new pharmacologic treatments, including some with novel approaches to drug delivery, have emerged in clinical development over the past few years. These agents include a variety of anticholinergics and others. In initial studies, some of the agents appear to compare favorably with existing therapies. Whether these promising results will hold up when subjected to large-scale, well-controlled clinical trials is unclear.

Similar articles

See all similar articles

Cited by 3 articles

References

    1. World J Urol. 2001 Nov;19(5):307-11 - PubMed
    1. J Am Geriatr Soc. 1998 Jan;46(1):8-13 - PubMed
    1. Xenobiotica. 1992 Jul;22(7):859-69 - PubMed
    1. J Urol. 1989 Jun;141(6):1350-2 - PubMed
    1. Urology. 2001 Mar;57(3):414-21 - PubMed

MeSH terms

Feedback